Josh Enomoto

Josh Enomoto

InvestorPlace Contributor

Brokering multi-million-dollar deals with some of the world’s biggest companies and providing in-depth marketing analyses, Josh Enomoto takes his firsthand knowledge of the corporate boardroom and delivers them across several media outlets. In addition to his work at InvestorPlace, Josh contributes content for Benzinga, TipRanks, EmergingGrowth and Blockster. He is also a guest expert at CGTN America.

While leaving no stone unturned regarding sector coverage, Josh has written extensively about cryptocurrencies. You can follow him on Blockster, a crypto-centric social media platform and on LinkedIn.

Recent Articles

Trade of the Day: Buy Beam Therapeutics Call Options as BEAM Stock Heads to $40

By Josh Enomoto, InvestorPlace Contributor

Beam Therapeutics recently got a vote of confidence from a Wall Street analyst, providing fuel for further upside in BEAM stock.

The 3 Best Uranium Stocks to Buy Now: July 2024

By Josh Enomoto, InvestorPlace Contributor

Energy consumption is on the rise thanks to advanced tech like AI. That’s great news for these best uranium stocks.

3 Disruptive Tech Stocks That Could Be the Next Apple: July 2024

By Josh Enomoto, InvestorPlace Contributor

Those looking to gamble on the next Apple must accept some risks. These are possible candidates for disruptive tech stocks.

What Is Going on With Regencell Bioscience (RGC) Stock Today?

By Josh Enomoto, InvestorPlace Contributor

Although Regencell Bioscience likely skyrocketed on its novel traditional therapeutics approach, RGC stock is highly speculative.

7 Oil Stocks to Buy as Political Forces Collide

By Josh Enomoto, InvestorPlace Contributor

With President Biden dropping out, Donald Trump has an easier road to victory. These are the oil stocks investors must watch now.

Load More